Werbung
Werbung
GOSS
Gossamer Bio, Inc. Common Stock
2.50
USDGesponsert
0.00
+0.20%
09. Jan., 15:58 UTC -5
Geschlossen
Nach-Markt
2.52
+0.02
+0.60%
GOSS Ergebnisberichte
Positives Überraschungsverhältnis
GOSS übertreffen die 14 der letzten 28Schätzungen.
50%
Nächster Bericht
Datum des nächsten Berichts
11. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$7.67M
/-$0.18
Implizierte Änderung von Q3 25 (Revenue/ EPS)
-42.28%
/-14.29%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
-18.19%
/+20.00%
Gossamer Bio, Inc. Common Stock earnings per share and revenue
On 05. Nov. 2025, GOSS reported earnings of -0.21 USD per share (EPS) for Q3 25, missing the estimate of -0.19 USD, resulting in a -7.36% surprise. Revenue reached 13.29 million, compared to an expected 6.46 million, with a 105.88% difference. The market reacted with a -2.53% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analysts forecast an EPS of -0.18 USD, with revenue projected to reach 7.67 million USD, implying an decrease of -14.29% EPS, and decrease of -42.28% in Revenue from the last quarter.
FAQ
What were Gossamer Bio, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Gossamer Bio, Inc. Common Stock reported EPS of -$0.21, missing estimates by -7.36%, and revenue of $13.29M, 105.88% above expectations.
How did the market react to Gossamer Bio, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -2.53%, changed from $2.37 before the earnings release to $2.31 the day after.
When is Gossamer Bio, Inc. Common Stock expected to report next?
The next earning report is scheduled for 11. März 2026.
What are the forecasts for Gossamer Bio, Inc. Common Stock's next earnings report?
Based on 10
analysts, Gossamer Bio, Inc. Common Stock is expected to report EPS of -$0.18 and revenue of $7.67M for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung